This report provides a comprehensive analysis of the application, benefits, and challenges of Artificial Intelligence (AI) within the healthcare industry, specifically focusing on Pfizer Inc. The report begins with an introduction to AI and its significance, followed by an examination of AI applications such as managing medical records and virtual nurses. It then delves into the capabilities of AI, including easy diagnosis and effective treatment strategies, while also addressing the challenges of AI implementation, such as data integrity, availability, and privacy concerns. The benefits of AI, including improved diagnosis, cost reduction, and efficient record management, are discussed. Furthermore, the report explores the legal, ethical, and social challenges associated with AI, including privacy issues, intellectual property concerns, and potential discrimination. The impact of AI on healthcare delivery, particularly in cardiovascular diagnosis, is highlighted. Finally, the report concludes by examining the challenges AI poses for patients and care providers, such as the lack of emotional connection and potential for caregiver laziness, offering a balanced perspective on the transformative potential and the critical considerations surrounding AI in healthcare.